News & Events

A vaccine for cancer is being developed by a new collaboration between Victoria Link, the Malaghan Institute, IRL and Grow Wellington.

IRL’s Distinguished Scientist, Dr Richard Furneaux, has been awarded the Hector Medal from the Royal Society of New Zealand.

GlycoSyn has nearly completed the manufacture of the key ingredient for a new drug designed to slow the progression of Parkinson’s Disease.

The active ingredient for a new drug designed to prevent genital herpes and HIV-AIDS will be manufactured in New Zealand with the signing of a major contract.

Starpharma Holdings Limited (ASX: SPL, USOTC:SPHRY) of Melbourne, Australia and Industrial Research Limited, New Zealand, today announced that they have entered into a joint venture to accelerate the development of carbohydrate functionalised dendrimers (glycodendrimers) for use in therapeutics, antigen presentation and as biologically active compounds.